ERTC Members

Initiated in 2004, the EURORDIS Round Table of Companies (ERTC) is a “club” of pharmaceutical companies with a common interest in rare diseases and orphan drug development.

Members agree to financially support EURORDIS activities and benefit from the development of a fruitful exchange between EURORDIS itself, government and regulatory authorities, academics and patients representatives. These exchanges mainly take place at closed bi-annual ERTC Workshops. Three levels of membership exist -Sapphire, Emerald and Ruby - the last one corresponding to the largest financial contribution.

Companies interested in the challenging field of rare disease are invited to become members of the EURORDIS Round Table of Companies. More about ERTC membership

Current Members

 
 
• Ruby Members
     
Alnylam Celgene CLS Behring Novartis Pharmaceuticals Pfizer
Shire Pharmaceuticals, Inc Genzyme Shire Pharmaceuticals, Inc  
• Emerald Members
     
Achillion Actelion Website Akcea Alexion Pharmaceuticals Inc. Bristol-Myers Squibb/AstraZeneca
Audentes Baxter Biogen Biomarin Bluebird Bio
Boehringer Ingelheim GmbH BMS Cytokinetics GRIFOLS GlaxoSmithKline
Horizon Pharma USA Incyte EUSA pHARMA LFB mapi

MSD Europe

Orphan Europe PTC Therapeutics Swedish Orphan International Vanda Pharmaceuticals/

Vertex

Wave Life Sciences

 

 
• Sapphire Members
     
Aegerion Amgen Akari Amicus Therapeutics Bayer Schering Pharma AG
Biopontis Alliance Chiesi Farmaceutici SpA Clinigen Group Cydan DLA Piper
Dompé Group ENZYVANT Généthon insmed Inceptua
insmed Mark Krueger & Associates  Inc. Leadiant biosciences Ovid
PharmaMar Prometic RegenXBio Sangamo Santhera
Spark UCB Ultragenyx Vifor Fresenius Medical Care
       
• Associate Members
     
Lysogene-Q    

* In-Kind member acting as liaison with NORD Corporate Council in the US and in recognition of support of the ERTC workshop dinners


Disclaimer
EURORDIS is not responsible for any content of other websites accessible from this page, nor does it endorse or in any respect warrant any third party products or services by virtue of any information, material or content referred to or included on, or linked from or to the EURORDIS website. EURORDIS does not endorse medicinal products, brands or health services.

 


Author: EURORDIS

 

>

Page created: 19/08/2009
Page last updated: 04/07/2017
 
 
The voice of rare disease patients in EuropeEURORDIS The international voice of people living with rare diseases, Rare Diseases International is a EURORDIS initiativeRare Disease International Bringing together patients, families and experts to share experiences in a moderated multilanguage forum, RareConnect is a EURORDIS initiative RareConnect An international awareness raising campaign taking place on the last day of February each year, Rare Disease Day is a EURORDIS initiativeRare Disease Day Join the largest gathering of rare disease stakeholders across Europe, at the biennial European Conference on Rare Diseases and Orphan Products. ECRD is a EURORDIS initiativeEuropean Conference on Rare Diseases